Stocklytics Platform
Asset logo for symbol ATRC
AtriCure
ATRC58
$34.01arrow_drop_down0.70%-$0.24
Asset logo for symbol ATRC
ATRC58

$34.01

arrow_drop_down0.70%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

AtriCure (ATRC) Stocklytics Forecast

According to the stock price prediction for AtriCure Inc (ATRC), the outlook appears positive. Analysts forecast steady growth for ATRC stock, with an optimistic projection for the next few years. The machine learning algorithms also indicate potential price appreciation for AtriCure Inc (ATRC).
Looking specifically at the stock price forecast for 2023, AtriCure Inc (ATRC) is expected to experience significant growth. Analysts anticipate a rise in the stock price, making it an attractive investment option. The price target for AtriCure Inc (ATRC) in 2023 is predicted to be higher than the current value.
add AtriCure  to watchlist

Keep an eye on AtriCure

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for AtriCure (ATRC) stock?

Analysts have set a target price of $58.9 for AtriCure (ATRC), based on forecasts from 30 analysts. The predicted price range extends from a high of $81 to a low of $42. This represents a potential increase of up to 138.17% and a decrease of 23.49% from the current price of $34.01. These forecasts are as of 2022 May 04.
help

What are the analyst ratings for AtriCure (ATRC) stock?

The analyst ratings for AtriCure (ATRC) are distributed as follows: 9 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering AtriCure .
help

What is the AI price prediction for AtriCure (ATRC) stock?

At present, there is no AI or machine-learning-based price prediction available for AtriCure (ATRC) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level